These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6895425)

  • 21. Studies on platelet plasma membranes. III. Membrane glycoprotein loss from circulating platelets in rabbits: inhibition by aspirin-dipyridamole and acceleration by thrombin.
    George JN; Lewis PC
    J Lab Clin Med; 1978 Feb; 91(2):301-6. PubMed ID: 621429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation of azolactoperoxidase. Evidence for the dependence of lacto-peroxidase activity on tyrosyl residues.
    Mäkinen KK; Mäkinen PL
    Biochem Biophys Res Commun; 1982 Apr; 105(4):1402-7. PubMed ID: 7103964
    [No Abstract]   [Full Text] [Related]  

  • 23. Identification of enzyme coupling sites with aromatic diazonium salts-a resonance raman study.
    Li TY; Chen JF; Watters KL; McFarland JT
    Arch Biochem Biophys; 1979 Oct; 197(2):477-86. PubMed ID: 41485
    [No Abstract]   [Full Text] [Related]  

  • 24. [Influence of platelet anti-aggregants on mitochondrial respiration of platelets].
    Rognoni F; Viganò V; Colombo Pirola L
    Boll Soc Ital Cardiol; 1977; 22(11):2140-6. PubMed ID: 754762
    [No Abstract]   [Full Text] [Related]  

  • 25. The influence of aspirin on postoperative platelet kinetics and venous thrombosis.
    Clagett GP; Schneider P; Rosoff CB; Salzman EW
    Surgery; 1975 Jan; 77(1):61-74. PubMed ID: 1109518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Drug-induced modification of thrombocyte turnover in patients with artificial heart valves].
    Kummer H; Hunziker HR; Althaus U
    Schweiz Med Wochenschr; 1974 Jan; 104(4):142-4. PubMed ID: 4811472
    [No Abstract]   [Full Text] [Related]  

  • 27. Platelet destruction during 24 hour membrane lung perfusion.
    Bloom S; Zapol W; Wonders T; Berger S; Salzman E
    Trans Am Soc Artif Intern Organs; 1974; 20A():299-305. PubMed ID: 4450351
    [No Abstract]   [Full Text] [Related]  

  • 28. Adenosine diphosphate (ADP)-induced alpha-granules release from platelets of native whole blood is reduced by ticlopidine but not by aspirin or dipyridamole.
    Pengo V; Boschello M; Marzari A; Baca M; Schivazappa L; Dalla Volta S
    Thromb Haemost; 1986 Oct; 56(2):147-50. PubMed ID: 3810554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antigenicity of influenza virus hemagglutinin following chemical modification.
    Laver WG; Air GM; Webster RG
    Virology; 1981 Jun; 111(2):538-48. PubMed ID: 6787797
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of antiadhesive drugs on platelet function and metabolism.
    Ulutin SB; Yaramanci TE; Ulutin ON
    Acta Univ Carol Med Monogr; 1972; 53():237-46. PubMed ID: 4670732
    [No Abstract]   [Full Text] [Related]  

  • 31. Platelet consumption by arterial prostheses: the effects of endothelialization and pharmacologic inhibition of platelet function.
    Harker LA; Slichter SJ; Sauvage LR
    Ann Surg; 1977 Nov; 186(5):594-601. PubMed ID: 411428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Membranoproliferative glomerulonephritis. A prospective clinical trial of platelet-inhibitor therapy.
    Donadio JV; Anderson CF; Mitchell JC; Holley KE; Ilstrup DM; Fuster V; Chesebro JH
    N Engl J Med; 1984 May; 310(22):1421-6. PubMed ID: 6371535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect on various platelet parameters of dipyridamole (225 mg/day) acetylsalicylic acid (150 mg/day) and their combination in healthy volunteers].
    Aguilar Muñoz A; de la Cruz Cortés JP; Martos Crespo F; de Pablo Molina J; Sánchez de la Cuesta F
    Med Clin (Barc); 1985 Nov; 85(18):743-5. PubMed ID: 4094486
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of aspirin and dipyridamole on platelet function, hematology, and blood chemistry of saturation divers.
    Philp RB; Bennett PB; Andersen JC; Fields GN; McIntyre BA; Francey I; Briner W
    Undersea Biomed Res; 1979 Jun; 6(2):127-46. PubMed ID: 531993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aspirin and other platelet active drugs. Relationship among dose, effectiveness, and side effects.
    Hirsh J; Salzman EW; Harker L; Fuster V; Dalen JE; Cairns JA; Collins R
    Chest; 1989 Feb; 95(2 Suppl):12S-18S. PubMed ID: 2644095
    [No Abstract]   [Full Text] [Related]  

  • 36. Proceedings: Comparison of in vivo and in vitro effects of platelet function suppressing drugs.
    Buchanan M; Hirsh J
    Thromb Diath Haemorrh; 1975 Nov; 34(2):552. PubMed ID: 1198423
    [No Abstract]   [Full Text] [Related]  

  • 37. Dipyridamole specifically decreases platelet-derived growth factor release from platelets.
    Takehara K; Igarashi A; Ishibashi Y
    Pharmacology; 1990; 40(3):150-6. PubMed ID: 2139727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Labeling of the proteins at the surface of the pancreatic zymogen granule using diazotized [125I]iodosulfanilic acid.
    Le Bel D
    Biochimie; 1988 Feb; 70(2):291-5. PubMed ID: 3134954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet deposition on human atherosclerotic lesions is decreased by low-dose aspirin in combination with dipyridamole.
    Sinzinger H; O'Grady J; Fitscha P
    J Int Med Res; 1988; 16(1):39-43. PubMed ID: 3350203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelets and prostaglandins in coronary artery disease. Rationale for use of platelet-suppressive drugs.
    Mehta J
    JAMA; 1983 May; 249(20):2818-23. PubMed ID: 6341645
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.